Why TTD Jumped, State Street, Agilent, and BlackRock Fell
Whenever the S&P 500 (IVV) adds a company to the index, the stock rises. The Trade Desk (TTD) will join the index on July 17. It will replace ANSYS (ANSS), a digital advertising platform. Synopsys (SNPS) is buying ANSYS.TTD stock gained 6.59% on Tuesday. If history repeats itself, it might keep rising from here. Palantir (PLTR), Robinhood (HOOD), and DataDog (DDOG) are some of the notable firms added to the index that subsequently traded higher. Super Micro Computers (SMCI), however, did not rise steadily. Filing delays hampered the SMCI stock performance last year. But SMCI stock is on the mend. Shares bottomed at below $20 to close at $53.17.In the asset management sector, State Street (STT) fell by 7.29% on July 15. It is forecasting total fee revenue to grow by 5% - 7%, up from a 3% - 5% prior outlook. Net interest income growth is flat Y/Y. STT stock fell in sympathy with bank stocks. Wells Fargo (WFC) lost 5.48% after posting Q2 results.BlackRock (BLK) dropped by 5.88%, setting a likely stock peak at $1,112.13. It posted net inflows of $68 billion in Q2. Despite record inflows for iShares ETFs, BLK stock fell as investors booked profits.BLK stock is a good long-term holding. Investors should consider accumulating shares whenever the price drops.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


